Wet Age-related Macular Degeneration
Showing 1 - 25 of >10,000
Intestinal Microbiome in Wet Age-related Macular Degeneration
Recruiting
- Age-Related Macular Degeneration
- Sample examination
-
Ioánnina, Epirus, Greece
- +1 more
Feb 23, 2023
Age-Related Macular Degeneration Trial in Toronto (NG101 AAV gene therapy)
Not yet recruiting
- Age-Related Macular Degeneration
- NG101 AAV gene therapy
-
Toronto, Ontario, CanadaVitreous Retina Macula Specialists of Toronto
Aug 2, 2023
Data of Intravitreal Aflibercept Injection in Patients of Wet
Completed
- Wet Age-related Macular Degeneration
- Aflibercept (Eylea, BAY86-5321)
-
Multiple Locations, IndiaMany Locations
Feb 2, 2023
Wet Age-related Macular Degeneration Trial in Beijing (RC28-E, Aflibercept)
Recruiting
- Wet Age-related Macular Degeneration
-
Beijing, Beijing, ChinaBeijing Hospital
Feb 3, 2023
Optical Coherence Tomography Angiography Criteria Of The
Not yet recruiting
- Choroidal Neovascular Membrane In Wet Age Related Macular Degeneration And In Pathological Myopia
- Optical coherence tomography angiography
- (no location specified)
Sep 27, 2022
Neovascular (Wet) Age-related Macular Degeneration (nAMD) Trial (EXG102-031)
Not yet recruiting
- Neovascular (Wet) Age-related Macular Degeneration (nAMD)
- EXG102-031
- (no location specified)
Jun 13, 2023
OCT Angiography in Wet AMD
Recruiting
- Neovascular (Wet) Age-related Macular Degeneration (AMD)
- Optical Coherence Tomography
-
Portland, OregonCasey Eye Institute, Oregon Health & Science University
Sep 20, 2022
s in Wet Age-related Macular Degeneration Which Have Never
Active, not recruiting
- Wet Age-related Macular Degeneration
- Aflibercept (Eylea, BAY86-5321)
-
Multiple Locations, Argentina
- +16 more
Jan 16, 2023
Wet Age-related Macular Degeneration Trial (Ranibizumab, SCT510A)
Not yet recruiting
- Wet Age-related Macular Degeneration
- (no location specified)
Jul 28, 2022
Wet Age-related Macular Degeneration Trial in Beijing (Aflibercept)
Completed
- Wet Age-related Macular Degeneration
-
Beijing, Beijing, ChinaPeking Union Medical College Hospital
Apr 19, 2022
Wet Age-related Macular Degeneration Trial in United States (Eyp-1901, Aflibercept 2Mg/0.05Ml Inj,Oph)
Recruiting
- Wet Age-related Macular Degeneration
- Eyp-1901
- Aflibercept 2Mg/0.05Ml Inj,Oph
-
Melbourne, Florida
- +4 more
Aug 18, 2022
Neovascular (Wet) Age-related Macular Degeneration Trial (BAT5906 injection, Lucentis)
Not yet recruiting
- Neovascular (Wet) Age-related Macular Degeneration
- BAT5906 injection
- Lucentis
- (no location specified)
Jun 26, 2022
Neovascular Age-related Macular Degeneration, Diabetic Macular Edema Trial in San Antonio (D-4517.2)
Recruiting
- Neovascular Age-related Macular Degeneration
- Diabetic Macular Edema
-
Los Angeles, California
- +11 more
Jan 11, 2023
Neovascular (Wet) Age-related Macular Degeneration Trial (Aflibercept(BAY86-5321, Eylea))
Not yet recruiting
- Neovascular (Wet) Age-related Macular Degeneration
- Aflibercept(BAY86-5321, Eylea)
- (no location specified)
Jul 22, 2022
Neovascular (Wet) Age-Related Macular Degeneration Trial in United States (4D-150 IVT, Aflibercept IVT)
Recruiting
- Neovascular (Wet) Age-Related Macular Degeneration
- 4D-150 IVT
- Aflibercept IVT
-
Oxnard, California
- +9 more
Jun 13, 2022
Healthy Volunteers, Wet Age-related Macular Degeneration Trial in Fukuoka (Placebo, KHK4951)
Recruiting
- Healthy Volunteers
- Wet Age-related Macular Degeneration
- Placebo
- KHK4951
-
Fukuoka, JapanHakata clinic
Nov 10, 2021
Neovascular Age-related Macular Degeneration Trial in United States (ADVM-022)
Recruiting
- Neovascular Age-related Macular Degeneration
- ADVM-022
-
Phoenix, Arizona
- +4 more
Sep 8, 2022
Age-related Wet Macular Degeneration Trial in United States (CG-P5 peptide, Placebo, Aflibercept Injection [Eylea])
Not yet recruiting
- Age-related Wet Macular Degeneration
- CG-P5 peptide
- +2 more
-
Augusta, Georgia
- +3 more
Nov 13, 2023
Wet Age-related Macular Degeneration Trial in Boston, Worcester (Intravitreal anti-VEGF, Intravitreal AAVCAGsCD59, Oral
Completed
- Wet Age-related Macular Degeneration
- Intravitreal anti-VEGF
- +2 more
-
Boston, Massachusetts
- +1 more
May 24, 2022
Wet Age-related Macular Degeneration Trial (SCB-420, Aflibercept)
Withdrawn
- Wet Age-related Macular Degeneration
- (no location specified)
Apr 12, 2022
Exudative Macular Degeneration, Wet Age-related Macular Degeneration Trial in Iowa City (Doxycycline Hyclate, Placebo)
Recruiting
- Exudative Macular Degeneration
- Wet Age-related Macular Degeneration
- Doxycycline Hyclate
- Placebo
-
Iowa City, IowaUniversity of Iowa Hospitals & Clinics Department of Ophthalmolo
Apr 5, 2022
Neovascular Age-related Macular Degeneration
Completed
- Age-related Macular Degeneration (AMD)
-
East Hanover, New JerseyNovartis Investigative Site
Dec 15, 2021
Diabetic Macular Edema (DME), Neovascular Age-Related Macular Degeneration (nAMD) Trial (aflibercept 8 mg PFS)
Not yet recruiting
- Diabetic Macular Edema (DME)
- Neovascular Age-Related Macular Degeneration (nAMD)
- aflibercept 8 mg PFS
- (no location specified)
Aug 3, 2023
s in Wet AMD in Active Smokers
Completed
- Wet Age-related Macular Degeneration
- Medical Data extraction
-
Brussels, BelgiumCHU Brugmann
Mar 7, 2022